To your first question: They still have $125 million in available credit.

Pfeffer: "Financial resources, including the remaining credit facility from Al amounted to $125.4 million as of March 31, 2013."

To your second question: I think they are just saying that the dropout rate was higher than expected, but since they over-enrolled they still will have enough patients completing the trial to get as least 90% power for the statistical evaluation. So, no problem.